| PDF (1MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-308511
- DOI to cite this document:
- 10.5283/epub.30851
Abstract
Background High-grade gliomas are amongst the most deadly human tumors. Treatment results are disappointing. Still, in several trials around 20% of patients respond to therapy. To date, diagnostic strategies to identify patients that will profit from a specific therapy do not exist. Methods In this study, we used serum-free short-term treated in vitro cell cultures to predict treatment response ...
Owner only: item control page